Amrize (NYSE:AMRZ) Insider Buys $179,386.56 in Stock

Amrize Ltd (NYSE:AMRZ) insider Jaime Hill purchased 3,184 shares of the firm’s stock in a transaction on Monday, March 9th. The stock was bought at an average price of $56.34 per share, for a total transaction of $179,386.56. Following the completion of the transaction, the insider directly owned 26,000 shares in the company, valued at approximately $1,464,840. The trade was a 13.96% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Amrize Stock Performance

Shares of AMRZ traded up $0.93 during trading hours on Tuesday, reaching $59.84. 1,468,978 shares of the company traded hands, compared to its average volume of 3,558,034. The stock’s fifty day moving average is $57.71 and its 200 day moving average is $53.53. The stock has a market cap of $33.10 billion and a P/E ratio of 24.36. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $65.94.

Amrize (NYSE:AMRZ) last released its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.59 by $0.03. The firm had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. Amrize’s revenue was down .4% compared to the same quarter last year.

Hedge Funds Weigh In On Amrize

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. acquired a new stake in Amrize in the 2nd quarter valued at $1,065,029,000. Norges Bank acquired a new position in Amrize during the fourth quarter worth $929,333,000. Dodge & Cox bought a new position in shares of Amrize during the second quarter valued at $622,085,000. Harris Associates L P bought a new position in shares of Amrize during the fourth quarter valued at $615,406,000. Finally, JPMorgan Chase & Co. bought a new stake in shares of Amrize in the 2nd quarter worth about $220,404,000.

Analysts Set New Price Targets

Several brokerages have recently weighed in on AMRZ. Vertical Research assumed coverage on Amrize in a report on Tuesday, November 25th. They set a “hold” rating and a $54.00 price objective on the stock. Berenberg Bank set a $70.00 target price on Amrize in a research report on Thursday, February 19th. Sanford C. Bernstein reiterated an “outperform” rating and set a $70.00 price target on shares of Amrize in a research note on Thursday, December 18th. Wall Street Zen raised shares of Amrize from a “sell” rating to a “hold” rating in a report on Sunday, March 1st. Finally, Wells Fargo & Company increased their price objective on shares of Amrize from $59.00 to $66.00 and gave the company an “overweight” rating in a research note on Thursday, February 19th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $64.14.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.